rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Douglas W. Calder

Director

Company insider

Files Form 4 as: Director, Zevra Therapeutics; Director, Lunai Bioworks; Fmr VP Strat Plan/Cap Markets, Biovest International; VP Strategic Plan/Cap Markets, Accentia Biopharmaceuticals.

Every Form 4 they filed

In numbers

Trades disclosed
17
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
4
Companies where not an officer
2
First trade
29 Feb 2012
Last trade
4 Jun 2026
Last filed
18 Jun 2026

Companies traded

Where they are an officer
Biovest InternationalOfficer · last 9 Jul 20130 buys · 0 sells
Accentia BiopharmaceuticalsOfficer · last 24 Aug 20120 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
ZVRA Zevra TherapeuticsDirector · Biotechnology · last 4 Jun 20260 buys · 0 sells
LNAI Lunai BioworksDirector · Biotechnology · last 4 Nov 20240 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
4 Jun 2026filed 18 Jun 2026ZVRA Zevra Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—30,000 at $0.00filing
4 Jun 2026filed 18 Jun 2026ZVRA Zevra Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—30,000 at $0.00filing
29 May 2025filed 30 May 2025ZVRA Zevra Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—30,000 at $0.00filing
4 Nov 2024filed 6 Nov 2024LNAI Lunai Bioworksoption or derivative · BiotechnologySEC FORM 4 Code A—120,968 at $0.00filing
13 May 2024filed 15 May 2024ZVRA Zevra Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—39,200 at $0.00filing
3 May 2023filed 11 May 2023ZVRA Zevra Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—58,800 at $0.00filing
9 Jul 2013filed 23 Aug 2013Biovest Internationaloption or derivativeSEC FORM 4 Code J—386,048 at $0.00filing
9 Jul 2013filed 23 Aug 2013Biovest Internationaloption or derivativeSEC FORM 4 Code J—494,900 at $0.00filing
9 Jul 2013filed 23 Aug 2013Biovest Internationaloption or derivativeSEC FORM 4 Code J—850,000 at $0.00filing
9 Jul 2013filed 23 Aug 2013Biovest Internationaloption or derivativeSEC FORM 4 Code J—250,000 at $0.00filing
9 Jul 2013filed 23 Aug 2013Biovest Internationaloption or derivativeSEC FORM 4 Code J—10,000 at $0.00filing
9 Jul 2013filed 23 Aug 2013Biovest Internationaloption or derivativeSEC FORM 4 Code J—20,000 at $0.00filing
9 Jul 2013filed 23 Aug 2013Biovest Internationaloption or derivativeSEC FORM 4 Code J—150,000 at $0.00filing
24 Aug 2012filed 14 Sep 2012Biovest Internationaloption or derivativeSEC FORM 4 Code A—386,048 at $0.00filing
24 Aug 2012filed 14 Sep 2012Accentia Biopharmaceuticalsoption or derivativeSEC FORM 4 Code A—410,695 at $0.00filing
30 Mar 2012filed 3 Apr 2012Biovest Internationaloption or derivativeSEC FORM 4 Code A—494,900 at $0.00filing
29 Feb 2012filed 2 Mar 2012Accentia Biopharmaceuticalsoption or derivativeSEC FORM 4 Code A—250,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Nobody else traded the same names lately.